000 00987 a2200277 4500
005 20250516075429.0
264 0 _c20120608
008 201206s 0 0 eng d
022 _a1758-1125
024 7 _a10.1258/phleb.2012.012s11
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeissner, M H
245 0 0 _aRationale and indications for aggressive early thrombus removal.
_h[electronic resource]
260 _bPhlebology
_cMar 2012
300 _a78-84 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aHeparin, Low-Molecular-Weight
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMechanical Thrombolysis
_xadverse effects
650 0 4 _aTime Factors
650 0 4 _aVenous Thrombosis
_xtherapy
650 0 4 _aWarfarin
_xtherapeutic use
773 0 _tPhlebology
_gvol. 27 Suppl 1
_gp. 78-84
856 4 0 _uhttps://doi.org/10.1258/phleb.2012.012s11
_zAvailable from publisher's website
999 _c21524286
_d21524286